Monica, James, et al
Importantly, these studies controlled for important covariates such as age, BMI, smoking, chronotype, and timing of sample collection, reinforcing the robustness of this association 177,178,179,180,181,182
We work with your prescribing doctor to find the lowest effective dose that achieves your health goals
Other companies are working on their own weight-loss pills: Eli Lilly, which makes Zepbound, is developing a GLP-1 pill, orforglipron, for weight loss and type 2 diabetes, with FDA approval anticipated for March 2026
Scaglia F, Wang Y, Singh RH et al : Defective urinary carnitine transport in heterozygotes for primary carnitine deficiency